Tender For tender for supply of adrenaline bitartrate injection 1mg per ml 1 into 1ml , albendazole oral suspension ip 200mg per 5ml 1 into 10ml , albendazole tablet ip 400mg 1 into 10 , amlodipine tablet 10mg 1 into 10 , amoxicillin capsule ip 250mg 1 into 10 , amoxycillin oral suspension ip 125mg per 5ml 1 into 60ml , atenolol tablet 50mg 1 into 14 , atorvastatin tablet 10mg 1 into 10 , budesonide inhalation 100mcg 1 into 1 , calamine lotion as per ip 1 into 50ml , vitamine c chewable ascorbic acide tablet 500mg 1 into 10 , ciprofloxacin hydrochloride eye drops ip 0 point 3percent w by v 1 into 5ml , ciprofloxaicin hydrochloride tablet ip 250mg 1 into 10 , clotrimazole cream ip1percent 1 into 15gm , co trimoxazole trimethoprim plus sulphamethoxazole ds tablet 160 plus 800mg 1 into 10 , co trimoxazole trimethoprim plus sulphamethoxazole suspension ip 40 plus 200mg per 5ml 1 into 60ml , diclofenac gel ip 1percent 1 into 30mg , diclofenac tablet 50mg 1 into 10 , dicyclomine hydrochloride tablet 10mg 1 into 10 , doxycycline capsule 100mg 1 into 10 , benzyl benzoate lotion 25percent 1 into 100ml , fruseminde tablet 40mg 1 into 10 , glimepiride tablet 2mg 1 into 10 , hydrocortisone sodium succinate injection 100mg 1 into 1 vial , hyoscine butyl bromide tablet ip 10mg 1 into 10 , ibuprofen tablet 200mg 1 into 10 , isosorbide 5 mononitrate per dinitrate tablet 10mg 1 into 10 , lactulose oral liquid 10g per 15ml 1 into 100ml , levo cetrizine tablet 5mg 1 into 10 , levothyroxine tablet 25mcg 100 into 1 bottle , lignocaine hydrochloride gel 2percent w by v 1 into 30gm , metoprolol tablet 25mg 1 into 10 , metronidazole benzoate oral suspension ip 200mg per 5ml 1 into 60ml , metronidazole tablet ip 400mg 1 into 10 , miconazole cream 2 percent w by w 1 into 15g , mupirocin ointment 25 w by w 1 into 5g , norfloxacin tablet ip 400mg 1 into 10 , ondansetron oral solution ip 2mg per 5ml 1 into 30ml , ondansetron tablet ip 4mg 1 into 10 , oral rehydration salts powder for solution sodium cloride 2 point 6 glucose anhydrous 13 point 5 potassium cloride 1 point 5 trisodium citrate dihydrate 2 point 91 into 20 point 5g , paracetamol paediatric oral suspension ip 250mg per 5ml 1 into 60ml , paracetamol paediatric oral suspension ip or paediatric syrup 125mg per 5ml , paracetamol tablet 500mg 1 into 10 , phenobarbitone tablet 30mg 1 into 10 , phenobarbitone tablet 60mg 1 into 10 ip or bp or usp , phenytoin sodium tablet 100mg 1 into 10 ip or bp or usp , povidone iodine ointment usp 5percent w by w 1 into 125g , ranitidine tablet 150mg 1 into 10 , salbutamol nebuliser solution bp 5mg per ml 1 into 15ml , silver sulphadiazine cream 125g 1 into 125g , aluminium hydroxide 250mg magnesium hydroxide 250mg activated dimethicone 50mg oxethazine 10mg suspension 250mg plus 250mg plus 50mg plus 10mg 1 into 200ml , zinc sulfate drops 20mg per ml 1 into 15ml , zinc sulfate drops 20mg per ml 1 into 15ml 1 into 60ml , alprazolam tablet 0 point 25mg 1 into 10 , gamma benzinc hexachloride lotion 1 percent w by v 1 into 30ml , sodium valproate and valproic acid cr tablet 500mg 1 into 10 , fluconazole capsule per tab 150mg 1 into 10 , ferrous sulphate per fumrate tablet iron equivalent to 20mg elemental iron andfolicacid 0 point 1mg 1 into 10 , telmisartan tablet 40mg 1 into 10 , sodium chloride nasal drops 0 point 65percent w by v 1 into 15ml , bromhexine syrup 4mg per 5ml 1 into 100ml , asprin acetylsalicylic acid 75mg 1 into 10 , carboxymethlcellulose drops 0 point 50 percent 1 into 1 , metformin sr tablet 500mg ip or bp or usp 1 into 10 , betamethasone dipropionate ointment 0point1percent w by w 1 into 15g , hydrogen peroxide solution 6 percent , neomycinplusbacitracin ointment 5mg plus 250iu per g 1 into 30g , wax dissolving solution solution contains parachloro benzene 2 percent w by v benzocaine ip 2 point 7 w by v chlorbutol ip 5percent w by v turpentine oil bp 15 percent w by v nil
Tender For online tender for the rate contract for the supply of medicines to various hospitals of government of haryana for a period of two years for group b medicines - iron andfolicacidtablet (wifs junior) containing dried ferrous sulphate ip equivalent to ferrous iron 45 mg andfolicacid ip 0.4 mg per tablet. tablet are sugar coated and pink colored tablets with only edible colors used tablet ferrous iron 45 mg andfolicacid ip 0.4 mg per tablet, elemental iron 60 mg + folicacid 500 mcg, sugar coated and red color tablet, ferrous sulphate + folicacid syrup 100 mg + 0.5 mg / 5 ml in a flavoured base / vehicle 50 ml bottle, ropp cap bottle with inert liner & bottle to be provided with a dispenser to dispense to 1 ml, 1.5ml and 2ml each time and packed in a mono carton, 50 ml bottle, albendazole chewable tablets 400 mg(the chewable tablets shall also comply with the test for disintegration and dissolution as per monograph given in international pharmacopeia as per requirement of goi)
Tender For e-tender for procurement of essential drug items under table-a, for one year from the date of aoc. - aceclofenac tab ip 100mg, albendazole tab. i.p. 400 mg., ambroxol syrup i.p. 30 mg / 5 ml, atorvastatin 40mg tab., drotavarine i.p. 40 mg tab, fluphenazine inj. 25mg, gabapentin tab/cap ip 300 mg, iron & folicacidtabs (wifs-junior). each sugar coated- pink coloured tablet contains: dried ferrous sulphate ip 150mg eq. to elemental iron 45 mg & folicacid ip 0.4 mg, iron & folicacidtabs each sugar coated - permitted edible blue colour tablet contains dried ferous sulphate ip - equivalent to 60 mg (elementary iron) & folicacid ip - 0.5mg (i.e. 500 mcg) as per rule 127 of the drugs and cosmetics rules, 1945, miconazole cream i.p 2%, quinine sulphate tab. i.p. 300 mg, sucralfate oral suspension 1g / 5ml, terbinafine 1% cream, important note: 1. all prospective bidders are requested to quote the rate in boq as per accounting unit & item specification as mentioned in the table-a. wrong quoting of the rate in boq will be dealt with as per penal provisions of the t&c of the tender.2. tendered quantity is just a tentative quantity and should not be treated as final. it may increase or decrease, as per need of the state. keeping this in mind, the supplier is not allowed to seek termination of the rate contract after finishing supply of tendered quantity.3. quality of the product supplied, may be ascertained by testing / physical examination by the experts at any stage of the tender period.4. the prospective bidders of the said tender are requested to make a declaration in affidavit under annexure vi(b) in case of sole manufacturer/importer (i.e. proprietary in nature).5. if the item(s) under sole manufacturer / importer is (are) proprietary in nature, quarterly intimation is solicited from the approved bidders positively regarding the status of their item(s) proprietary in nature, otherwise their item(s) will be blocked in the smis.6. in case of tie bid, decision will be taken by the tia as per g.o. no. 2320-f(y), dated 07.06.2022 issued from finance department audit branch (group t).